Howard A. Fine

29.2k total citations · 10 hit papers
235 papers, 21.3k citations indexed

About

Howard A. Fine is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Howard A. Fine has authored 235 papers receiving a total of 21.3k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Genetics, 97 papers in Molecular Biology and 63 papers in Cancer Research. Recurrent topics in Howard A. Fine's work include Glioma Diagnosis and Treatment (134 papers), Brain Metastases and Treatment (31 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Howard A. Fine is often cited by papers focused on Glioma Diagnosis and Treatment (134 papers), Brain Metastases and Treatment (31 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Howard A. Fine collaborates with scholars based in United States, Canada and China. Howard A. Fine's co-authors include Jeongwu Lee, Jay S. Loeffler, Patrick Y. Wen, Yuri Kotliarov, Benjamin Purow, Qin Su, Sandra Pastorino, Aiguo Li, Svetlana Kotliarova and Peter McL. Black and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Howard A. Fine

231 papers receiving 20.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

2006 1.8k citations Jeongwu Lee, Svetlana Kotliarova et al. profile →
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

2008 1.2k citations Teri Kreisl, Lyndon Kim et al. Journal of Clinical Oncology profile →
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain

2006 692 citations Lixin Sun, Qin Su et al. profile →
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1993 689 citations Howard A. Fine, Jay S. Loeffler et al. profile →
microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma

2008 630 citations Jeongwu Lee, Howard A. Fine et al. Cancer Research profile →
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

2009 503 citations Kevin Woolard, Jeongwu Lee et al. profile →
Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases

1995 447 citations Howard A. Fine, Peter McL. Black et al. profile →
Modeling Patient-Derived Glioblastoma with Cerebral Organoids

2019 323 citations Amanda Linkous, Matija Snuderl et al. profile →
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

2019 301 citations Richard A. Morgan, Steven A. Feldman et al. profile →
Diffuse Glioma Heterogeneity and Its Therapeutic Implications

2021 267 citations James Nicholson, Howard A. Fine Cancer Discovery profile →

Peers

Countries citing papers authored by Howard A. Fine

Since Specialization

Citations

This map shows the geographic impact of Howard A. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard A. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard A. Fine more than expected).

Fields of papers citing papers by Howard A. Fine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard A. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard A. Fine. The network helps show where Howard A. Fine may publish in the future.

Co-authorship network of co-authors of Howard A. Fine

This figure shows the co-authorship network connecting the top 25 collaborators of Howard A. Fine. A scholar is included among the top collaborators of Howard A. Fine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard A. Fine. Howard A. Fine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas 2024 ·American Journal of Neuroradiology ·(unknown), (unknown), (unknown), Rohan Ramakrishna, Susan C. Pannullo, Theodore H. Schwartz, Joseph R. Osborne, Rajiv Magge, Howard A. Fine, Babacar Cisse, Philip E. Stieg, Eaton Lin, Michelle Roytman, Joshua D. Palmer, Nicolas A. Karakatsanis, David J. Pisapia, Benjamin Liechty, Jonathan Knisely, Jana Ivanidze	2
2	Stem cell modeling of nervous system tumors 2024 ·Disease Models & Mechanisms ·Frank B. Furnari, Corina Anastasaki, Shan Bian, Howard A. Fine, Tomoyuki Koga, Lu Q. Le, Fausto J. Rodriguez, David H. Gutmann	0
3	Glioblastoma: Not Just Another Cancer 2024 ·Cancer Discovery ·Howard A. Fine	5
4	Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution 2023 ·Cancer Research ·Allison R. Pine, Stéfano M. Cirigliano, Richa Singhania, James Nicholson, Bárbara da Silva, Christina S. Leslie, Howard A. Fine	14
5	Pluripotent stem cell-derived epithelium misidentified as brain microvascular endothelium requires ETS factors to acquire vascular fate 2021 ·Proceedings of the National Academy of Sciences ·Tyler M. Lu, Sean Houghton, Tarig Magdeldin, José Gabriel Barcia Durán, Andrew P. Minotti, Amanda M. Snead, Andrew A. Sproul, Duc-Huy T. Nguyen, Jenny Xiang, Howard A. Fine, Zev Rosenwaks, Lorenz Studer, Shahin Rafii, Dritan Agalliu, David Redmond, Raphaël Lis	146
6	Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas 2020 ·Cancer Discovery ·Allison R. Pine, Stéfano M. Cirigliano, James Nicholson, Yang Hu, Amanda Linkous, Ken Miyaguchi, Lincoln Edwards, Richa Singhania, Theodore H. Schwartz, Rohan Ramakrishna, David J. Pisapia, Matija Snuderl, Olivier Elemento, Howard A. Fine	105
7	Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients 2020 ·Neurosurgical FOCUS ·Chibawanye Ene, Patrick J. Cimino, Howard A. Fine, Eric C. Holland	4
8	Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc 2012 ·Cancer Research ·Hong Sug Kim, Kevin Woolard, Chen Lai, Peter Bauer, Dragan Maric, Hua Song, Aiguo Li, Svetlana Kotliarova, Wei Zhang, Howard A. Fine	29
9	Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma 2012 ·Human Gene Therapy ·Richard A. Morgan, Laura A. Johnson, Jeremy L. Davis, Zhili Zheng, Kevin Woolard, Elizabeth A. Reap, Steven A. Feldman, Nachimuthu Chinnasamy, Chien-Tsun Kuan, Hua Song, Wei Zhang, Howard A. Fine, Steven A. Rosenberg	246
10	Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma 2010 ·Journal of Clinical Oncology ·Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain, Martin J. van den Bent, Alain Carpentier, Lawrence Cher, Warren Mason, Michael Weller, Shengyan Hong, Luna Musib, Astra M. Liepa, Donald Thornton, Howard A. Fine	359
11	A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas 2009 ·Clinical Cancer Research ·Teri Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Svetlana Kotliarova, Jennifer Walling, Luna Musib, Donald Thornton, Paul S. Albert, Howard A. Fine	40
12	Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes 2009 ·Cancer Research ·Aiguo Li, Jennifer Walling, Susie Ahn, Yuri Kotliarov, Qin Su, Martha Quezado, J. Carl Oberholtzer, John Park, Jean C. Zenklusen, Howard A. Fine	166
13	Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research 2009 ·Molecular Cancer Research ·Subha Madhavan, (unknown), Yuri Kotliarov, Himanso Sahni, Howard A. Fine, Kenneth H. Buetow	331
14	Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial 2009 ·Journal of Clinical Oncology ·Stuart A. Grossman, Xiaobu Ye, Marc C. Chamberlain, Tom Mikkelsen, Tracy T. Batchelor, Serena Desideri, Steven Piantadosi, Joy Fisher, Howard A. Fine	131
15	Occupational exposure to magnetic fields and the risk of brain tumors 2009 ·Neuro-Oncology ·Joseph Coble, Mustafa Dosemeci, Patricia A. Stewart, Aaron Blair, Joseph D. Bowman, Howard A. Fine, William R. Shapiro, Robert G. Selker, Jay S. Loeffler, Peter McL. Black, Martha S. Linet, Peter D. Inskip	27
16	Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-κB, and Glucose Regulation 2008 ·Cancer Research ·Svetlana Kotliarova, Sandra Pastorino, Lara Kovell, Yuri Kotliarov, Hua Song, Wei Zhang, Rolanda Bailey, Dragan Maric, Jean C. Zenklusen, Jeongwu Lee, Howard A. Fine	220
17	Genetic variation in insulin-like growth factors and brain tumor risk 2008 ·Neuro-Oncology ·Stefan Lönn, Nathaniel Rothman, William R. Shapiro, Howard A. Fine, Robert G. Selker, Peter M. Black, Jay S. Loeffler, Amy Hutchinson, Peter D. Inskip	22
18	Glioma invadomics - identification and validation of novel targets for glioma invasion in-vivo 2006 ·Cancer Research ·Linsey B. Reavie, Tim Demuth, Dominique B. Hoelzinger, Jessica L. Rennert, Ruth E. Bristol, Satoko Nakada, Jean C. Zenklusen, Howard A. Fine, T. Mikkelsen, Michael E. Berens	1
19	Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury 2004 ·Journal of Clinical Investigation ·Lixin Sun, Jeongwu Lee, Howard A. Fine	199
20	Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury 2004 ·Journal of Clinical Investigation ·Lixin Sun, Jeongwu Lee, Howard A. Fine	209

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact